证券记录 · 已归档季度
XERS
Xeris Biopharma Holdings, Inc. · Healthcare · Biotechnology
15被追踪持有人
-1Δ持有人
41.39M持有股份
$193.31M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -6.2% ·
股份流向 +1.9% ·
净新建仓位 -6.7%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 93 | +3 | 81.56M | $645.48M | +8 | −4 |
| Q1 2026 | 92 | +4 | 77.44M | $449.36M | +7 | −4 |
| Q4 2025 | 88 | +2 | 77.86M | $611.14M | +3 | — |
| Q3 2025 | 17 | 0 | 48.63M | $395.88M | +1 | −2 |
| Q2 2025 | 15 | -1 | 41.39M | $193.31M | — | −1 |
| Q1 2025 | 13 | +3 | 18.95M | $104.02M | +4 | −1 |
| Q4 2024 | 10 | +1 | 14.55M | $49.32M | +1 | — |
| Q3 2024 | 8 | -1 | 9.23M | $26.32M | — | −1 |
| Q2 2024 | 9 | — | 8.75M | $19.69M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 11.54M | — | $53.87M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 9.82M | — | $45.85M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 9.82M | — | $45.85M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 9.82M | — | $45.85M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 3.84M | +25.6% | $17.91M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (被动) | 3.78M | +13.8% | $17.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Geode Capital Management ✦ (被动) | 3.65M | +7.2% | $17.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Geode Capital Management ✦ (被动) | 3.65M | +7.2% | $17.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Millennium Management ✦ | 2.93M | +26.6% | $13.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 2.06M | -5.0% | $9.60M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 1.21M | +36.4% | $5.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 1.05M | +10.8% | $4.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 1.05M | +10.8% | $4.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 1.05M | +10.8% | $4.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 1.05M | +10.8% | $4.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Norges Bank ✦ (被动) | 561.70K | -31.8% | $2.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Wellington Management ✦ | 399.29K | +1.8% | $1.86M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Wellington Management ✦ | 399.29K | +1.8% | $1.86M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 399.29K | +1.8% | $1.86M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 326.42K | — | $1.52M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 326.42K | — | $1.52M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Fidelity (FMR) ✦ | 326.42K | — | $1.52M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 153.27K | -13.1% | $716,000 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Point72 Asset Management ✦ | 45.10K | -49.0% | $210,617 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | Gotham Asset Management ✦ | 32.77K | +101.9% | $153,017 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Citadel Advisors | $7.40M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 229 持有人, 93.59M 股份, $532.36M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 12
Pieper Steven
Officer · 5.00K 股 · $42,500
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 31
SC 13G — VANGUARD CAPITAL MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据